Status:
UNKNOWN
The Wolverhampton Assessment Tool, a Tool for Patient-reported Wellbeing in the Context of Prostate Cancer
Lead Sponsor:
University of Wolverhampton
Collaborating Sponsors:
The Royal Wolverhampton Hospitals NHS Trust
Conditions:
Advanced Prostate Carcinoma
Eligibility:
MALE
Phase:
NA
Brief Summary
This is a study of the Wolverhampton Assessment Tool (WATapp), a five-item questionnaire for patients with advanced or metastatic prostate cancer to say how they feel normally in terms of pain, urinar...
Detailed Description
It is widely recognised that patient-reported outcomes give a measure of overall effect of clinicians' actions on patients and that they can be used to guide the management of the patient's condition....
Eligibility Criteria
Inclusion
- born male
- diagnosed with advanced or metastatic prostate cancer
- able to read and speak English
Exclusion
- not born male
- not diagnosed with advanced or metastatic prostate cancer
- not able to read and speak English
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04851639
Start Date
September 1 2020
End Date
March 30 2025
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Wolverhampton Hospital NHS Trust
Wolverhampton, United Kingdom, WV10 0QP